Vaccine · Pathogen-derived preparation that provides acquired immunity to an infectious disease · YYNN

Vaccine

? TBD

Pathogen-derived preparation that provides acquired immunity to an infectious disease

Ratings 0

Nobody has rated this yet. Be the first!

Facets 1

Influences rating

vaccine engineering

Subclasses 11

Influences rating

Attenuated vaccine

Vaccine that uses a weakened form of the germ

Hepatitis B vaccine

Vaccine against hepatitis B

Class of vaccines against human papillomavirus

Vaccine that either treats existing cancer or prevents development of cancer

combined vaccine

two or more vaccines in a single dosage form

suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease

Measles vaccine

Vaccine used to prevent measles

Zika virus vaccine

Vaccine in development

Rubella vaccine

Vaccine used to prevent rubella

therapeutic vaccine

vaccine or vaccine candidate for use in treatment of a disease

Subject of 33

Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

scientific article

A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes

scientific article published on 03 March 2008

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

scientific article

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

scientific article published on February 20, 2014

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

scientific article

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag

scientific article

Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon

scientific article

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

scientific article published on May 2004

Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.

scientific article published on 2 August 2006

Lists 0